BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36054024)

  • 1. Diffusion-Weighted Magnetic Resonance Imaging and Morphological Characteristics Evaluation for Outcome Prediction of Primary Debulking Surgery for Advanced High-Grade Serous Ovarian Carcinoma.
    Li H; Lu J; Deng L; Guo Q; Lin Z; Zhao S; Ge H; Qiang J; Gu Y; Liu Z
    J Magn Reson Imaging; 2023 May; 57(5):1340-1349. PubMed ID: 36054024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative staging of ovarian cancer: comparison between ultrasound, CT and whole-body diffusion-weighted MRI (ISAAC study).
    Fischerova D; Pinto P; Burgetova A; Masek M; Slama J; Kocian R; Frühauf F; Zikan M; Dusek L; Dundr P; Cibula D
    Ultrasound Obstet Gynecol; 2022 Feb; 59(2):248-262. PubMed ID: 33871110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional tumour burden of peritoneal carcinomatosis derived from DWI could predict incomplete tumour debulking in advanced ovarian carcinoma.
    Lee EYP; An H; Perucho JAU; Chiu KWH; Hui ES; Chu MMY; Ngan HYS
    Eur Radiol; 2020 Oct; 30(10):5551-5559. PubMed ID: 32405751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI with diffusion-weighted imaging to predict feasibility of complete cytoreduction with the peritoneal cancer index (PCI) in advanced stage ovarian cancer patients.
    Engbersen MP; Van' T Sant I; Lok C; Lambregts DMJ; Sonke GS; Beets-Tan RGH; van Driel WJ; Lahaye MJ
    Eur J Radiol; 2019 May; 114():146-151. PubMed ID: 31005166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic Resonance Imaging and Diffusion Weighted Imaging-Based Histogram in Predicting Mesenchymal Transition High-Grade Serous Ovarian Cancer.
    Cai SQ; Song ZY; Wu MR; Lu JJ; Sun WW; Wei F; Li HM; Qiang JW; Li YA; Zhu J; Zhou JJ; Zeng MS
    Acad Radiol; 2023 Jun; 30(6):1118-1128. PubMed ID: 35909051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-weighted magnetic resonance imaging in peritoneal carcinomatosis from suspected ovarian cancer: Diagnostic performance in correlation with surgical findings.
    Garcia Prado J; González Hernando C; Varillas Delgado D; Saiz Martínez R; Bhosale P; Blazquez Sanchez J; Chiva L
    Eur J Radiol; 2019 Dec; 121():108696. PubMed ID: 31683251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical evidence-based comparison of [
    Li X; Lv X; Quan Z; Han T; Tang Y; Liu Y; Wang M; Li G; Ye J; Wang J; Lan X; Zhang X; Li M; Liu S; Kang F; Wang J
    Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1773-1785. PubMed ID: 38197954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A modified diffusion-weighted magnetic resonance imaging-based model from the radiologist's perspective: improved performance in determining the surgical resectability of advanced high-grade serous ovarian cancer.
    Lu J; Guo Q; Zhang Y; Zhao S; Li R; Fu Y; Feng Z; Wu Y; Li R; Li X; Qiang J; Wu X; Gu Y; Li H
    Am J Obstet Gynecol; 2024 Mar; ():. PubMed ID: 38432417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancer.
    Roze JF; Hoogendam JP; van de Wetering FT; Spijker R; Verleye L; Vlayen J; Veldhuis WB; Scholten RJ; Zweemer RP
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012567. PubMed ID: 30298516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of platinum resistance for advanced high-grade serous ovarian carcinoma using MRI-based radiomics nomogram.
    Li H; Cai S; Deng L; Xiao Z; Guo Q; Qiang J; Gong J; Gu Y; Liu Z
    Eur Radiol; 2023 Aug; 33(8):5298-5308. PubMed ID: 36995415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases.
    Dresen RC; De Vuysere S; De Keyzer F; Van Cutsem E; Prenen H; Vanslembrouck R; De Hertogh G; Wolthuis A; D'Hoore A; Vandecaveye V
    Cancer Imaging; 2019 Jan; 19(1):1. PubMed ID: 30616608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative prediction of miliary changes in the small bowel mesentery in advanced high-grade serous ovarian cancer using MRI radiomics nomogram.
    Guo Q; Lin Z; Lu J; Li R; Wu L; Deng L; Qiang J; Wu X; Gu Y; Li H
    Abdom Radiol (NY); 2023 Mar; 48(3):1119-1130. PubMed ID: 36651979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-weighted magnetic resonance imaging for the pre-operative evaluation of epithelial ovarian cancer patients.
    Feng Z; Fu Y; Li R; Li H; Lu J; Chen X; Ju X; Wu X; Wen H
    Gynecol Oncol; 2023 Jul; 174():142-147. PubMed ID: 37207498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic Resonance Assessment of Peritoneal Carcinomatosis: Is There a True Benefit From Diffusion-Weighted Imaging?
    Cianci R; Delli Pizzi A; Patriarca G; Massari R; Basilico R; Gabrielli D; Filippone A
    Curr Probl Diagn Radiol; 2020; 49(6):392-397. PubMed ID: 31248709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-operative evaluation of epithelial ovarian cancer patients: Role of whole body diffusion weighted imaging MR and CT scans in the selection of patients suitable for primary debulking surgery. A single-centre study.
    Rizzo S; De Piano F; Buscarino V; Pagan E; Bagnardi V; Zanagnolo V; Colombo N; Maggioni A; Del Grande M; Del Grande F; Bellomi M; Aletti G
    Eur J Radiol; 2020 Feb; 123():108786. PubMed ID: 31862634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between High Diffusion-Weighted Imaging-Derived Functional Tumor Burden of Peritoneal Carcinomatosis and Overall Survival in Patients with Advanced Ovarian Carcinoma.
    An H; Perucho JAU; Chiu KWH; Hui ES; Chu MMY; Ngu SF; Ngan HYS; Lee EYP
    Korean J Radiol; 2022 May; 23(5):539-547. PubMed ID: 35506527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and Predictive Value of the Peritoneal Cancer Index in Primary Advanced Epithelial Ovarian Cancer Patients After Complete Cytoreductive Surgery: Study of Tumor Bank Ovarian Cancer.
    Gasimli K; Braicu EI; Richter R; Chekerov R; Sehouli J
    Ann Surg Oncol; 2015 Aug; 22(8):2729-37. PubMed ID: 25672560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel index for preoperative, non-invasive prediction of macro-radical primary surgery in patients with stage IIIC-IV ovarian cancer-a part of the Danish prospective pelvic mass study.
    Karlsen MA; Fagö-Olsen C; Høgdall E; Schnack TH; Christensen IJ; Nedergaard L; Lundvall L; Lydolph MC; Engelholm SA; Høgdall C
    Tumour Biol; 2016 Sep; 37(9):12619-12626. PubMed ID: 27440204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of peritoneal metastases with DW-MRI, CT, and FDG PET/CT before cytoreductive surgery for advanced stage epithelial ovarian cancer.
    Mikkelsen MS; Petersen LK; Blaakaer J; Marinovskij E; Rosenkilde M; Andersen G; Bouchelouche K; Iversen LH
    Eur J Surg Oncol; 2021 Aug; 47(8):2134-2141. PubMed ID: 33812768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of
    Jónsdóttir B; Ripoll MA; Bergman A; Silins I; Poromaa IS; Ahlström H; Stålberg K
    Cancer Imaging; 2021 Apr; 21(1):34. PubMed ID: 33849649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.